Pancreatic Cancer Research

ResearcherFudan UniversityActive in the last 2 years

Shun Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2694-9559; OpenAlex author ID A5100424627. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Disruption of ACTG1 potentiates anti-TIM-3 immunotherapy by reprogramming the immunosuppressive microenvironment via the CSF3/CSF3R axis in pancreatic cancer. Co-author DOI 10.3389/fimmu.2026.1820470↗
  2. The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives. Co-author DOI 10.1038/s41392-021-00659-4↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qiongzhu Dong · 2 shared papers, 2021–2026 · strength 0.35
  2. Xinxin Ling · 1 shared paper, 2026 · strength 0.24
  3. Le Zhu · 1 shared paper, 2026 · strength 0.24
  4. Feng Yang · 1 shared paper, 2021 · strength 0.11
  5. Zhefang Wang · 1 shared paper, 2021 · strength 0.11
  6. Beiyuan Hu · 1 shared paper, 2021 · strength 0.11
  7. Yan Zheng · 1 shared paper, 2021 · strength 0.11
  8. Jiayan Yan · 1 shared paper, 2021 · strength 0.11
  9. Bo Kong · 1 shared paper, 2021 · strength 0.11
  10. Christiane J. Bruns · 1 shared paper, 2021 · strength 0.11
  11. Yue Zhao · 1 shared paper, 2021 · strength 0.11
  12. Deliang Fu · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.